The FDA announced it will expand the use of unannounced inspections at foreign Life Science manufacturing facilities. This marks a clear shift in enforcement strategy — one that introduces even more unpredictability and pressure for global Life Science supply chains.
FDA Press Announcement
For manufacturers, the implications are serious:
- Increased risk of sudden non-compliance findings
- Greater anxiety around readiness for inspection
- Potential supply disruptions or facility shutdowns
This is where we come in.
We help manufacturers and consultants stay continuously inspection-ready — no surprises, no scramble.
It automatically monitors and evaluates your compliance in real-time. Our AI engine flags gaps before they become violations — allowing teams to resolve issues proactively rather than react under pressure.
Think of it as your always-on compliance co-pilot:
→ No need to wait for a scheduled audit
→ No more “inspection panic”
→ No risk of costly oversights
In a world of surprise inspections, compliance can’t be a snapshot.
It has to be continuous.
If you support Life Science manufacturers — or are one — now is the time to adopt tools that match the FDA’s new tempo.
Let’s talk about how we can help you stay ready, resilient, and inspection-proof.